Join
Live feed
·
PRReleasevia Quantisnow
BiomX Inc. logo

BiomX Announces Positive Topline Results from Phase 2 Trial Evaluating BX211 for the Treatment of Diabetic Foot Osteomyelitis (DFO)

ByQuantisnow·Wall Street's wire, on your screen.
PHGE· BiomX Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PHGE (BiomX Inc.) and more on Quantisnow.